Login

H. Wang

ORCID: 0009-0000-0657-3043
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5109999770
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Cancer-related molecular mechanisms research
  • Network Security and Intrusion Detection
  • Medical Imaging Techniques and Applications
  • Management of metastatic bone disease
  • Information and Cyber Security
  • MicroRNA in disease regulation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Advanced Malware Detection Techniques
  • Thyroid Cancer Diagnosis and Treatment
  • Energy Efficient Wireless Sensor Networks
  • Neuroendocrine Tumor Research Advances
  • RNA modifications and cancer
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Advanced Radiotherapy Techniques
  • PARP inhibition in cancer therapy
  • Security in Wireless Sensor Networks

University of Electronic Science and Technology of China
 2024

Tianjin Medical University Cancer Institute and Hospital
 2011-2020

 GD3N: Adaptive clustering-based detection of selective forwarding attacks in WSNs under variable harsh environments
OPENALEX - Publications 
H. Wang Xinyu Huang Yuanming Wu

10.1016/j.ins.2024.120375 article EN Information Sciences 2024-02-29
 CT quantitative parameters to predict the invasiveness of lung pure ground-glass nodules (pGGNs)
OPENALEX - Publications 
Liying Han P. Zhang Y. Wang Zhipeng Gao H. Wang and 2 more Xin Li Zhimao Ye

10.1016/j.crad.2017.12.021 article EN Clinical Radiology 2018-02-03
 Percutaneous cryoablation of liver metastases from breast cancer: Initial experience in 17 patients
OPENALEX - Publications 
W. Zhang Haipeng Yu Zhuming Guo B. Li Tongguo Si and 2 more Xueling Yang H. Wang

10.1016/j.crad.2013.09.014 article EN Clinical Radiology 2013-11-14
 Multimodality Therapy Is Recommended for Limited-Stage Combined Small-Cell Esophageal Carcinoma
OPENALEX - Publications 
Maobin Meng H. Wang Nicholas G. Zaorsky Chao Jiang Dong Qian and 3 more Lujun Zhao Zhiyong Yuan P. Wang

10.1016/j.ijrobp.2014.05.1117 article EN International Journal of Radiation Oncology*Biology*Physics 2014-09-01
 Detecting selective forwarding attacks on cloud
OPENALEX - Publications 
H. Wang Yuhang Wang Yuanming Wu

10.1016/j.engappai.2024.109248 article EN Engineering Applications of Artificial Intelligence 2024-09-08
 Preoperative CT features for prediction of ALK gene rearrangement in lung adenocarcinomas
OPENALEX - Publications 
H. Wang Y. Wang H. Zhang Ying Han Q. Li and 1 more Zhimao Ye

10.1016/j.crad.2020.03.026 article EN Clinical Radiology 2020-04-16
 LIMD1 Radiosensitizes Human Non-Small Cell Lung Cancer Cells Via Inhibiting NF-kB Signaling
OPENALEX - Publications 
Zhi Wu M. Qiu Maobin Meng Yan Guo Dong Qian and 3 more Zhiyong Yuan H. Wang Xiaojuan Zeng

10.1016/j.ijrobp.2015.07.1915 article EN International Journal of Radiation Oncology*Biology*Physics 2015-10-17
 Feasibility and Efficacy of Stereotactic Body Radiation Therapy Using Robotic Radiosurgery as Curative Treatment for Metastatic Thyroid Carcinoma
OPENALEX - Publications 
H. Wang Maobin Meng Chao Jiang Dong Qian Lujun Zhao and 2 more Zhiyong Yuan P. Wang

10.1016/j.ijrobp.2014.05.2561 article EN International Journal of Radiation Oncology*Biology*Physics 2014-09-01
 296P miR-17 ∼ 92 activates the canonical NF-&kgr;B signaling by targeting TNFAIP3, CYLD and Rnf11 in ABC-DLBCL lymphoma
OPENALEX - Publications 
Xin Wang H. Wang Chengfeng Bi Xuan Zhang Xin Huang and 9 more Xiaoyan Zhang Javeed Iqbal George W. Wright Louis M. Staudt Wing C. Chan Timothy W. McKeithan P. Wang Han Zhang Kai Fu

10.1093/annonc/mdv526.12 article EN publisher-specific-oa Annals of Oncology 2015-12-01
 REMOVED: P57 NIMOTUZUMAB IN COMBINATION WITH DOCETAXEL AND CARBOPLATIN AS TREATMENT FOR ADVANCED NON-SMALL-CELL-LUNG-CANCER
OPENALEX - Publications 
Da Qi Q. Wang Chongbiao Huang Yong Li Yaning Yang and 5 more Yan Cui Lijing Xin Jie Xu H. Wang Jiayi Zheng

This article has been removed: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). abstract removed at the request of Editor-in-Chief and author because it contains a drug dosage error which could have serious health consequences. The contained for drug, docetaxel. corrected should read as follows: Background: We evaluated efficacy nimotuzumab combined with docetaxel carboplatin (TP) treatment advanced non-small-cell-lung-cancer (NSCLC), well...

10.1016/j.ejcsup.2011.02.058 article EN cc-by-nc-nd European Journal of Cancer Supplements 2011-04-01
Coming Soon ...